My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lemsip Cold & Flu Capsules with CaffeineParacetamol 500mg Caffeine 65mg



Reckitt Benckiser Ireland LtdPA0979/024/001

Main Information

Trade NameLemsip Cold & Flu Capsules with CaffeineParacetamol 500mg Caffeine 65mg
Active SubstancesParacetamol
Caffeine
Dosage FormCapsule, hard
Licence HolderReckitt Benckiser Ireland Ltd
Licence NumberPA0979/024/001

Group Information

ATC CodeN02BE Anilides
N02BE01 paracetamol

Status

License statusWithdrawn
Withdrawn Date12/10/2022
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceGeneral sale in blister packs containing not more than 12 unit dosage forms. The product concerned should contain paracetamol as its only active analgesic substance and only one pack should be supplied in the course of any one retail transaction. Retail sale through pharmacies only in blister packs containing not more than 24 unit dosage forms. Not more than two such packs should be supplied in the course of any one retail transaction unless a valid prescription exists. Packs containing more than 24 unit dosage forms may be supplied to pharmacies for use by pharmacists provided the label states that they are for dispensing purposes only. Packs containing more than 50 unit dosage forms are prescription only. Promotion to the general public for packs containing not more than 24 unit dosage forms. Promotion to healthcare professionals only for packs containing more than 24 unit dosage forms.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print